Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Crohn's disease Stories

2013-05-22 16:24:56

- New data demonstrate a critical relationship between antibodies to adalimumab (ATA) and clinical response in IBD patients - SAN DIEGO, May 22, 2013 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the eighteen abstracts relating to its proprietary diagnostic platform were presented at Digestive Disease Week (DDW) 2013. The abstracts (see full list below) highlight Prometheus' innovative technologies aimed at...

2013-05-21 08:28:58

ORLANDO, Fla., May 21, 2013 /PRNewswire-USNewswire/ -- Research presented at Digestive Disease Week® (DDW) explores new methods for managing digestive health through diet and lifestyle. Individuals suffering from Crohn's disease are often plagued by reduced muscle strength, fatigue and poor quality of life. These symptoms can remain even when patients are in remission. A randomized, double blind, placebo-controlled study found for the first time that vitamin D supplementation...

2013-05-20 11:18:40

Studies presented at DDW® 2013 highlight benefits of vitamin D, diet changes, acupuncture Research presented at Digestive Disease Week® (DDW) explores new methods for managing digestive health through diet and lifestyle. Individuals suffering from Crohn's disease are often plagued by reduced muscle strength, fatigue and poor quality of life. These symptoms can remain even when patients are in remission. A randomized, double blind, placebo-controlled study found for the first...

2013-05-20 08:27:33

BETHESDA, Md., May 20, 2013 /PRNewswire/ -- TNI BioTech, Inc. (OTCQB: TNIB), a biotech company combating fatal diseases through the activation and mobilization of the body's immune system using patented immunotherapy, announced its common stock is trading on the OTC Markets' OTCQB marketplace under the ticker symbol "TNIB" commencing May 17, 2013. Investors will be able to view the real-time Level II stock quotes for TNIB at http://www.otcmarkets.com/stock/TNIB/quote. Noreen...

2013-05-17 00:20:17

First selective JAK1 inhibitor to enter Phase 2 studies in Crohn's disease NORTH CHICAGO, Ill. and MECHELEN, Belgium, May 17, 2013 /PRNewswire/ -- Galapagos NV (Euronext: GLPG) and AbbVie (NYSE: ABBV) announced today an extension of their GLPG0634 clinical development collaboration to include Crohn's disease. Galapagos will fund and complete a Phase 2 program in Crohn's disease, which is designed to facilitate rapid progression into Phase 3. Upon successful completion of the...

2013-05-16 08:28:20

BETHESDA, Md., May 16, 2013 /PRNewswire/ -- TNI BioTech, Inc., (OTC PINK: TNIB), a biotech company combating fatal diseases through the activation and mobilization of the body's immune system using its patented immunotherapy, issued a letter to its shareholders from CEO Noreen Griffin and the company's board of directors. The letter follows: Dear Shareholders, The board of directors of TNI BioTech, Inc. is very pleased to provide an update on the progress made over the last year. This...

2013-05-15 08:29:48

PRINCETON, N.J., May 15, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that it has initiated the first clinical study for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease. The program has...

2013-04-25 08:35:11

BETHESDA Md., April 25, 2013 /PRNewswire/ -- TNI BioTech, Inc. (OTC PINK: TNIB) is pleased to announce that they have named Terry Lierman from the Summit Global Ventures as a strategic advisor to the company. In this capacity, Mr. Lierman will provide strategic and tactical direction to improve operational productivity for the company's growth plans. "Terry Lierman is renowned on capitol hill for both his political skills and his passionate support of improved healthcare and funding for...

2013-04-22 12:31:47

BETHESDA, Md., April 22, 2013 /PRNewswire/ -- TNI BioTech, Inc. (OTC Pink: TNIB) (www.tnibiotech.com), announced it has filed its Form 10 to become a fully reporting public company with the Securities and Exchange Commission. Some of the highlights of the filing are the acquisition and licensing agreements between TNI BioTech and Dr. Nicholas P. Plotnikoff, Dr. Bernard Bihari, Professor Fengping Shan, Dr. Jill Smith and LDN Research LLC, and Pennsylvania State University. In addition to the...

2013-04-15 23:00:43

Annual CCFA Spring Patient Education Day at Thomas Jefferson Hospital On Sunday, April 28, 2013. Philadelphia, PA (PRWEB) April 15, 2013 On Sunday, April 28, 2013, the Philadelphia/Delaware Valley Chapter of the Crohn´s & Colitis Foundation of America (CCFA) will proudly hold the Annual Spring Patient Education Day at Thomas Jefferson Hospital. This free program provides a supportive environment for patients, families and caregivers to learn about Crohn's disease and ulcerative...